New role for Natural Killers!August 28, 2008Scientists at the University of York have discovered a new role for a population of white blood cells, which may lead to improved treatments for chronic infections and cancer. Natural Killer (or NK) cells are abundant white blood cells that were recognised over 30 years ago as being able to kill cancer cells in the test tube. Since that time, a role for NK cells in activating other white blood cells (including 'T' lymphocytes and phagocytes) and in directing how the immune system responds to a wide range of infections has also been established. Because of these properties, NK have been widely regarded as being of benefit in the fight against cancer and infection, and methods to increase NK cell activity underpin a range of new experimental anti-cancer drugs and anti-infectives.
However, a research team in the University's Centre for Immunology and Infection and led by Professor Paul Kaye, has now demonstrated that NK cells also make chemicals that inhibit immune responses. The research, published in the latest issue of the journal Immunity, has shown that in an experimental model of the tropical disease visceral leishmaniasis, too many NK cells can actually make the disease worse. They have identified that NK cells produce a chemical called interleukin-10 that can counteract many of the otherwise beneficial effects of these cells. Professor Kaye said: "Other researchers have suggested in the past that NK cells might not always be good for you, but we now have the first direct evidence that this can actually be the case. Although we have worked on an infectious disease, the same is likely to be true for NK cells in cancer. So, in practical terms, it means that we need to consider more carefully exactly how we use therapies that affect NK cells, to maximize their beneficial role." The new findings also open up the potential of developing new drugs that specifically target the beneficial properties of NK cells, and which leave their inhibitory properties switched off. Conversely, in autoimmune diseases, where the immune system is too active, it may be possible to stimulate NK cells to turn it off. University of York | |||||||||||||||||||||
|
Related White Blood Cells Current Events and White Blood Cells News Articles Researchers identify cell group key to Lyme disease arthritis A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease. St. Jude identifies genomic causes of a certain type of leukemia relapse Scientists at St. Jude Children's Research Hospital have identified distinctive genetic changes in the cancer cells of children with acute lymphoblastic leukemia (ALL) that cause relapse. The finding offers a pathway to designing treatments for ALL relapse in children and, ultimately, in adults. Study unmasks how ovarian tumors evade immune system Scientists at Johns Hopkins have determined how the characteristic shedding of fatty substances, or lipids, by ovarian tumors allows the cancer to evade the body's immune system, leaving the disease to spread unchecked Researchers discover strategy for predicting the immunity of vaccines In the first study of its kind, researchers at the Yerkes National Primate Research Center and Emory Vaccine Center, Emory University, have developed a multidisciplinary approach involving immunology, genomics and bioinformatics to predict the immunity of a vaccine without exposing individuals to infection. UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents. ADHD medications do not cause genetic damage in children In contrast to recent findings, two of the most common medications used to treat attention deficit hyperactivity disorder (ADHD) do not appear to cause genetic damage in children who take them as prescribed, according to a new study by researchers at the National Institutes of Health (NIH) and Duke University Medical Center. Battling bacteria in the blood: Researchers tackle deadly infections It's a leading cause of death, but no one knows for sure how and why it happens. It's a major source of health care costs, adding days or weeks to the hospital stays and lost work time of millions of people. But no one fully understands how best to fight it. Mayo Clinic Researchers Find Predictive Tests and Early Treatment Delay Progression of Blood Cell Cancer Mayo Clinic researchers say they have moved closer to their goal of providing personalized care for a common blood cell cancer. New therapeutic target identified for rheumatoid arthritis Researchers at Hospital for Special Surgery have identified a potential new therapeutic target that could be used to treat inflammatory disorders, such as rheumatoid arthritis. Previously unknown immune cell may help those with Crohn's and colitis The tonsils and lymphoid tissues in the intestinal tract that help protect the body from external pathogens are the home base of a rare immune cell newly identified by researchers at Washington University School of Medicine in St. Louis. More White Blood Cells Current Events and White Blood Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||